TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04548700

Liposomal Mitoxantrone Hydrochloride Injection,Cyclophosphamide, Vincristine and Prednisone in the Treatment of PTCL

Cause of deathFunding or business Automatic label, confidence 0.5, unverified. How labels are made.
“The sponsor has adjusted its R\&D strategy.”

The sponsor’s own words in the registry.

Life of this trial

20202021202220232024Registered2020-08-28Started2020-12-24Primary completion2023-06-30Stopped2023-11-30

Vital statistics

Status
Terminated
Phase
Phase 1
Sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Sponsor type
Industry
Conditions
Treatment-naïve; Peripheral T Cell Lymphoma
Interventions
Dose-finding stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone; Dose-expansion stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
Participants
38
Sites
1
Countries
China

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.